Cargando…
Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study
Glucocorticoids (GCs) are the cornerstone of the therapy in many autoimmune and inflammatory diseases. However, it is well known that their use is a double edged sword, as their beneficial effects are associated almost universally with unwanted effects, as, for example glucocorticoid-induced osteopo...
Autores principales: | Ortego-Jurado, Miguel, Callejas-Rubio, José-Luis, Ríos-Fernández, Raquel, González-Moreno, Juan, González Ramírez, Amanda Rocío, González-Gay, Miguel A., Ortego-Centeno, Norberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466436/ https://www.ncbi.nlm.nih.gov/pubmed/26124976 http://dx.doi.org/10.1155/2015/729451 |
Ejemplares similares
-
Giant cell arteritis: is the clinical spectrum of the disease changing?
por: González-Gay, Miguel Á., et al.
Publicado: (2019) -
Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19
por: Callejas Rubio, José Luis, et al.
Publicado: (2020) -
One world, one health: The novel coronavirus COVID-19 epidemic()
por: Callejas Rubio, José Luis, et al.
Publicado: (2020) -
COVID-19 vaccine literacy in patients with systemic autoimmune diseases
por: Correa-Rodríguez, María, et al.
Publicado: (2022) -
Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008)